CIE-10

CIE-10-código Y49

You are here: Inicio > CIE-10 > V01-Y99 > Y40-Y84 > Y40-Y59

- CIE-10
Clasificación Internacional de Enfermedades
- V01-Y99
Causas externas de morbilidad y de mortalidad
- Y40-Y84
Complicaciones de la atención médica y quirúrgica
- Y40-Y59
Drogas, medicamentos y sustancias biológicas causantes de efectos adversos en su uso terapéutico

Y49

Efectos adversos de drogas psicotrópicas, no clasificadas en otra parte

CIE-10 Сódigo Y49 para Efectos adversos de drogas psicotrópicas, no clasificadas en otra parte

Excluye: barbitúricos NCOP (Y47.0)

benzodiazepinas (Y47.1)

cafeína (Y50.2)

cocaína (Y48.3)

metacualona (Y47.8)

depresores del apetito [anoréxicos] (Y57.0)

Y49.0
Efectos adversos de antidepresivos tricíclicos y tetracíclicos
Y49.1
Efectos adversos de antidepresivos inhibidores de la monoaminooxidasa
Y49.2
Efectos adversos de otros antidepresivos, y los no especificados
Y49.3
Efectos adversos de antipsicóticos y neurolépticos fenotiazínicos
Y49.4
Efectos adversos de neurolépticos de la butirofenona y tioxantina
Y49.5
Efectos adversos de otros antipsicóticos y neurolépticos
Y49.6
Efectos adversos de psicodislépticos [alucinógenos]
Y49.7
Efectos adversos de psicoestimulantes con abuso potencial
Y49.8
Efectos adversos de otras drogas psicotrópicas, no clasificadas en otra parte
Y49.9
Efectos adversos de drogas psicotrópicas no especificadas
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us